Park Ha Biological Technology is trading 13.6% up at $0.52 in after-hours trading, extending a sharp technical rebound following a heavy sell-off in the biotech sector earlier this week.
- The move appears driven by speculative buying and broader sector strength rather than any new company-specific filings or fundamental news.
- Shares are continuing to recover ground after being caught in the recent industry-wide downward pressure.